FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Claude Meares

Research Profile

Chemicals & Drugs

Living Beings

Co-author Network

Publications

TOP 3
Claude F Meares; Masayuki Yokoyama
Introduction to gene silencing and delivery.
Tolulope A Aweda; Claude F Meares
Combination of isothermal titration calorimetry and time-resolved luminescence for high affinity antibody-ligand interaction thermodynamics and kinetics.
Tolulope A Aweda; Heather E Beck; David L Boucher; Simon R Cherry; Vahid Eskandari; David L Kukis; Bernadette V Marquez; Gregory S Mitchell; Claude F Meares
New covalent capture probes for imaging and therapy, based on a combination of binding affinity and disulfide bond formation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Claude Meares (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Claude F Meares; Masayuki Yokoyama
Introduction to gene silencing and delivery.
Accounts of chemical research 2012;45(7):959-60.
2012: Tolulope A Aweda; Claude F Meares
Combination of isothermal titration calorimetry and time-resolved luminescence for high affinity antibody-ligand interaction thermodynamics and kinetics.
Methods (San Diego, Calif.) 2012;56(2):145-53.
2011: Tolulope A Aweda; Heather E Beck; David L Boucher; Simon R Cherry; Vahid Eskandari; David L Kukis; Bernadette V Marquez; Gregory S Mitchell; Claude F Meares
New covalent capture probes for imaging and therapy, based on a combination of binding affinity and disulfide bond formation.
Bioconjugate chemistry 2011;22(8):1479-83.
2011: Jason L J Dearling; Stephan D Voss; Patricia S Dunning; Erin Snay; Frederic Fahey; Suzanne V Smith; James S Huston; Claude F Meares; S Ted Treves; Alan B Packard
Imaging cancer using PET--the effect of the bifunctional chelator on the biodistribution of a (64)Cu-labeled antibody.
Nuclear medicine and biology 2011;38(1):29-38.
2010: Jeffrey J Day; Bernadette V Marquez; Heather E Beck; Tolulope A Aweda; Prasad D Gawande; Claude F Meares
Chemically modified antibodies as diagnostic imaging agents.
Current opinion in chemical biology 2010;14(6):803-9.
2010: Jai Woong Seo; Lisa M Mahakian; Azadeh Kheirolomoom; Hua Zhang; Claude F Meares; Riccardo Ferdani; Carolyn J Anderson; Katherine W Ferrara
Liposomal Cu-64 labeling method using bifunctional chelators: poly(ethylene glycol) spacer and chelator effects.
Bioconjugate chemistry 2010;21(7):1206-15.
2010: Tolulope A Aweda; Heather E Beck; Anna M Wu; Liu H Wei; Wolfgang A Weber; Claude F Meares
Rates and equilibria for probe capture by an antibody with infinite affinity.
Bioconjugate chemistry 2010;21(4):784-91.
2009: Sarah M Cheal; Mindy Ng; Brianda Barrios; Zheng Miao; Amir K Kalani; Claude F Meares
Mapping protein-protein interactions by localized oxidation: consequences of the reach of hydroxyl radical.
Biochemistry 2009;48(21):4577-86.
2009: Claude F Meares
Targeted instant immunity.
Nature biotechnology 2009;27(5):452-3.
2008: Jai Woong Seo; Hua Zhang; David L Kukis; Claude F Meares; Katherine W Ferrara
A novel method to label preformed liposomes with 64Cu for positron emission tomography (PET) imaging.
Bioconjugate chemistry 2008;19(12):2577-84.
2008: Liu Hua Wei; Tove Olafsen; Caius G Radu; Isabel J Hildebrandt; Mark R McCoy; Michael E Phelps; Claude F Meares; Anna M Wu; Johannes Czernin; Wolfgang A Weber
Engineered antibody fragments with infinite affinity as reporter genes for PET imaging.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(11):1828-35.
2008: Claude F Meares
The chemistry of irreversible capture.
Advanced drug delivery reviews 2008;60(12):1383-8.
2008: Zheng Miao; Mark R McCoy; Diment D Singh; Brianda Barrios; Oliver L Hsu; Sarah M Cheal; Claude F Meares
Cysteinylated protein as reactive disulfide: an alternative route to affinity labeling.
Bioconjugate chemistry 2008;19(1):15-9.
2006: Nathaniel G Butlin; Claude F Meares
Antibodies with infinite affinity: origins and applications.
Accounts of chemical research 2006;39(10):780-7.
2006: Todd M Corneillie; Paul A Whetstone; Claude F Meares
Irreversibly binding anti-metal chelate antibodies: Artificial receptors for pretargeting.
Journal of inorganic biochemistry 2006;100(5-6):882-90.
2006: Susan Lee; Nicolas L Young; Paul A Whetstone; Sarah M Cheal; W Henry Benner; Carlito B Lebrilla; Claude F Meares
Method to site-specifically identify and quantitate carbonyl end products of protein oxidation using oxidation-dependent element coded affinity tags (O-ECAT) and nanoliquid chromatography Fourier transform mass spectrometry.
Journal of proteome research 2006;5(3):539-47.
2005: Carol M Richman; Sally J DeNardo; Robert T O'Donnell; Aina Yuan; Sui Shen; Desiree S Goldstein; Joseph M Tuscano; Ted Wun; Helen K Chew; Primo Lara; David L Kukis; Arutselvan Natarajan; Claude F Meares; Kathleen R Lamborn; Gerald L DeNardo
High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast cancer by using a MUC-1 monoclonal antibody, m170, linked to indium-111/yttrium-90 via a cathepsin cleavable linker with cyclosporine to prevent human anti-mouse antibody.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(16):5920-7.
2004: Todd M Corneillie; Kelvin C Lee; Paul A Whetstone; Jeremy P Wong; Claude F Meares
Irreversible engineering of the multielement-binding antibody 2D12.5 and its complementary ligands.
Bioconjugate chemistry 2004;15(6):1392-402.
2004: Todd M Corneillie; Paul A Whetstone; Kelvin C Lee; Jeremy P Wong; Claude F Meares
Converting weak binders into infinite binders.
Bioconjugate chemistry 2004;15(6):1389-91.
2004: Paul A Whetstone; Hiromichi Akizawa; Claude F Meares
Evaluation of cleavable (Tyr3)-octreotate derivatives for longer intracellular probe residence.
Bioconjugate chemistry 2004;15(3):647-57.
2004: Paul A Whetstone; Nathaniel G Butlin; Todd M Corneillie; Claude F Meares
Element-coded affinity tags for peptides and proteins.
Bioconjugate chemistry 2004;15(1):3-6.
2003: Todd M Corneillie; Andrew J Fisher; Claude F Meares
Crystal structures of two complexes of the rare-earth-DOTA-binding antibody 2D12.5: ligand generality from a chiral system.
Journal of the American Chemical Society 2003;125(49):15039-48.
2003: Claude F Meares; AJ Chmura; Molly S Orton; Todd M Corneillie; Paul A Whetstone
Molecular tools for targeted imaging and therapy of cancer.
Journal of molecular recognition : JMR 2003;16(5):255-9.
2003: Todd M Corneillie; Paul A Whetstone; Andrew J Fisher; Claude F Meares
A rare earth-DOTA-binding antibody: probe properties and binding affinity across the lanthanide series.
Journal of the American Chemical Society 2003;125(12):3436-7.
2003: Claude F Meares; Saul A Datwyler; Brian D Schmidt; Jeffrey Owens; Akira Ishihama
Principles and methods of affinity cleavage in studying transcription.
Methods in enzymology 2003;371():82-106.
2002: Brian D Schmidt; Claude F Meares
Proteolytic DNA for mapping protein-DNA interactions.
Biochemistry 2002;41(13):4186-92.
2002: AJ Chmura; Brian D Schmidt; Donald T Corson; Stacey L Traviglia; Claude F Meares
Electrophilic chelating agents for irreversible binding of metal chelates to engineered antibodies.
Journal of controlled release : official journal of the Controlled Release Society 2002;78(1-3):249-58.
2001: DA Goodwin; Claude F Meares
Advances in pretargeting biotechnology.
Biotechnology advances 2001;19(6):435-50.
2001: Gerald L DeNardo; Sally J DeNardo; David L Kukis; Robert T O'Donnell; Sui Shen; Gary R Mirick; Claude F Meares
Metabolite production in patients with lymphoma after radiometal-labeled antibody administration.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(9):1324-33.
2001: Michael T Marr; Saul A Datwyler; Claude F Meares; Jeffrey W Roberts
Restructuring of an RNA polymerase holoenzyme elongation complex by lambdoid phage Q proteins.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(16):8972-8.
2001: AJ Chmura; M S Orton; Claude F Meares
Antibodies with infinite affinity.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(15):8480-4.
2001: S P Lubic; DA Goodwin; Claude F Meares; C Song; M Osen; M Hays
Biodistribution and dosimetry of pretargeted monoclonal antibody 2D12.5 and Y-Janus-DOTA in BALB/c mice with KHJJ mouse adenocarcinoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(4):670-8.
2001: John C Voss; J Wu; W L Hubbell; V Jacques; Claude F Meares; H R Kaback
Helix packing in the lactose permease of Escherichia coli: distances between site-directed nitroxides and a lanthanide.
Biochemistry 2001;40(10):3184-8.
2001: Saul A Datwyler; Claude F Meares
Artificial iron-dependent proteases.
Metal ions in biological systems 2001;38():213-54.
2000: G L DeNardo; S J DeNardo; Robert T O'Donnell; Linda A Kroger; David L Kukis; Claude F Meares; David S Goldstein; Sui Shen
Are radiometal-labeled antibodies better than iodine-131-labeled antibodies: comparative pharmacokinetics and dosimetry of copper-67-, iodine-131-, and yttrium-90-labeled Lym-1 antibody in patients with non-Hodgkin's lymphoma.
Clinical lymphoma 2000;1(2):118-26.
2000: Saul A Datwyler; Claude F Meares
Protein-protein interactions mapped by artificial proteases: where sigma factors bind to RNA polymerase.
Trends in biochemical sciences 2000;25(9):408-14.
2000: J Lee; J T Owens; I Hwang; Claude F Meares; Sydney Kustu
Phosphorylation-induced signal propagation in the response regulator ntrC.
Journal of bacteriology 2000;182(18):5188-95.
2000: Gerald L DeNardo; Robert T O'Donnell; Sui Shen; Linda A Kroger; Aina Yuan; Claude F Meares; David L Kukis; Sally J DeNardo
Radiation dosimetry for 90Y-2IT-BAD-Lym-1 extrapolated from pharmacokinetics using 111In-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(5):952-8.
2000: JA Bown; Annie Kolb; Claude F Meares; Akira Ishihama; Stephen D Minchin; Stephen J W Busby
Positioning of region 4 of the Escherichia coli RNA polymerase sigma(70) subunit by a transcription activator.
Journal of bacteriology 2000;182(10):2982-4.
2000: Barry W Wessels; Claude F Meares
Physical and chemical properties of radionuclide therapy.
Seminars in radiation oncology 2000;10(2):115-22.
2000: D T Corson; Claude F Meares
Efficient multigram synthesis of the bifunctional chelating agent (S)-1-p-isothiocyanatobenzyl-diethylenetriaminepentaacetic acid [correction of diethylenetetraminepentaacetic acid].
Bioconjugate chemistry 2000;11(2):292-9.
1999: Stacey L Traviglia; Saul A Datwyler; D Yan; Akira Ishihama; Claude F Meares
Targeted protein footprinting: where different transcription factors bind to RNA polymerase.
Biochemistry 1999;38(48):15774-8.
1999: Gary R Mirick; Robert T O'Donnell; Sally J DeNardo; Sui Shen; Claude F Meares; Gerald L DeNardo
Transfer of copper from a chelated 67Cu-antibody conjugate to ceruloplasmin in lymphoma patients.
Nuclear medicine and biology 1999;26(7):841-5.
1999: L M Rose; C T Deng; Susan L Scott; Cheng-Yi Xiong; K R Lamborn; Paul H Gumerlock; Gerald L DeNardo; Claude F Meares
Critical Lym-1 binding residues on polymorphic HLA-DR molecules.
Molecular immunology 1999;36(11-12):789-97.
1999: Frédéric Colland; Nobuyuki Fujita; D Kotlarz; JA Bown; Claude F Meares; Akira Ishihama; Annie Kolb
Positioning of sigma(S), the stationary phase sigma factor, in Escherichia coli RNA polymerase-promoter open complexes.
The EMBO journal 1999;18(14):4049-59.
1999: James J Peterson; Claude F Meares
Enzymatic cleavage of peptide-linked radiolabels from immunoconjugates.
Bioconjugate chemistry 1999;10(4):553-7.
1999: DA Goodwin; Claude F Meares
Pretargeted peptide imaging and therapy.
Cancer biotherapy & radiopharmaceuticals 1999;14(3):145-52.
1999: Stacey L Traviglia; Saul A Datwyler; Claude F Meares
Mapping protein-protein interactions with a library of tethered cutting reagents: the binding site of sigma 70 on Escherichia coli RNA polymerase.
Biochemistry 1999;38(14):4259-65.
1999: Gerald L DeNardo; David L Kukis; Sui Shen; DA Denardo; Claude F Meares; Sally J DeNardo
67Cu-versus 131I-labeled Lym-1 antibody: comparative pharmacokinetics and dosimetry in patients with non-Hodgkin's lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(3):533-41.
1999: James J Peterson; R H Pak; Claude F Meares
Total solid-phase synthesis of 1,4,7,10-tetraazacyclododecane-N,N', N'',N'''-tetraacetic acid-functionalized peptides for radioimmunotherapy.
Bioconjugate chemistry 1999;10(2):316-20.
1999: Sally J DeNardo; Gerald L DeNardo; David L Kukis; Sui Shen; Linda A Kroger; DA Denardo; Desiree S Goldstein; Gary R Mirick; QA Salako; LF Mausner; Suresh C Srivastava; Claude F Meares
67Cu-2IT-BAT-Lym-1 pharmacokinetics, radiation dosimetry, toxicity and tumor regression in patients with lymphoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(2):302-10.
1999: JA Bown; JT Owens; Claude F Meares; Nobuyuki Fujita; Akira Ishihama; Stephen J W Busby; Stephen D Minchin
Organization of open complexes at Escherichia coli promoters. Location of promoter DNA sites close to region 2.5 of the sigma70 subunit of RNA polymerase.
The Journal of biological chemistry 1999;274(4):2263-70.
1998: David L Kukis; Sally J DeNardo; Gerald L DeNardo; Robert T O'Donnell; Claude F Meares
Optimized conditions for chelation of yttrium-90-DOTA immunoconjugates.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(12):2105-10.
1998: Gerald L DeNardo; Linda A Kroger; Claude F Meares; Carol M Richman; QA Salako; Sui Shen; Kathleen R Lamborn; James J Peterson; Laird A Miers; G R Zhong; Sally J DeNardo
Comparison of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA)-peptide-ChL6, a novel immunoconjugate with catabolizable linker, to 2-iminothiolane-2-[p-(bromoacetamido)benzyl]-DOTA-ChL6 in breast cancer xenografts.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(10):2483-90.
1998: DA Goodwin; Claude F Meares; M Osen
Biological properties of biotin-chelate conjugates for pretargeted diagnosis and therapy with the avidin/biotin system.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(10):1813-8.
1998: K Bin Song; M Won; Claude F Meares
Expression of recombinant Lym-1 single-chain Fv in Escherichia coli.
Biotechnology and applied biochemistry 1998;28 ( Pt 2)():163-7.
1998: James J Peterson; Claude F Meares
Cathepsin substrates as cleavable peptide linkers in bioconjugates, selected from a fluorescence quench combinatorial library.
Bioconjugate chemistry 1998;9(5):618-26.
1998: Gerald L DeNardo; Sally J DeNardo; David L Kukis; Robert T O'Donnell; Sui Shen; Desiree S Goldstein; Linda A Kroger; QA Salako; DA Denardo; Gary R Mirick; LF Mausner; Suresh C Srivastava; Claude F Meares
Maximum tolerated dose of 67Cu-2IT-BAT-LYM-1 for fractionated radioimmunotherapy of non-Hodgkin's lymphoma: a pilot study.
Anticancer research 1998;18(4B):2779-88.
1998: JT Owens; AJ Chmura; K Murakami; Nobuyuki Fujita; Akira Ishihama; Claude F Meares
Mapping the promoter DNA sites proximal to conserved regions of sigma 70 in an Escherichia coli RNA polymerase-lacUV5 open promoter complex.
Biochemistry 1998;37(21):7670-5.
1998: JT Owens; R Miyake; K Murakami; AJ Chmura; Nobuyuki Fujita; Akira Ishihama; Claude F Meares
Mapping the sigma70 subunit contact sites on Escherichia coli RNA polymerase with a sigma70-conjugated chemical protease.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(11):6021-6.
1998: Sally J DeNardo; David L Kukis; Laird A Miers; Michelle D Winthrop; Linda A Kroger; QA Salako; Sui Shen; Kathleen R Lamborn; Paul H Gumerlock; Claude F Meares; Gerald L DeNardo
Yttrium-90-DOTA-peptide-chimeric L6 radioimmunoconjugate: efficacy and toxicity in mice bearing p53 mutant human breast cancer xenografts.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(5):842-9.
1998: X Feng; R H Pak; Linda A Kroger; J K Moran; DG DeNardo; Claude F Meares; Gerald L DeNardo; Sally J DeNardo
New anti-Cu-TETA and anti-Y-DOTA monoclonal antibodies for potential use in the pre-targeted delivery of radiopharmaceuticals to tumor.
Hybridoma 1998;17(2):125-32.
1998: R Miyake; K Murakami; JT Owens; D P Greiner; O N Ozoline; Akira Ishihama; Claude F Meares
Dimeric association of Escherichia coli RNA polymerase alpha subunits, studied by cleavage of single-cysteine alpha subunits conjugated to iron-(S)-1-[p-(bromoacetamido)benzyl]ethylenediaminetetraacetate.
Biochemistry 1998;37(5):1344-9.
1998: S Nicholson; C S Gooden; V Hird; A Maraveyas; P Mason; HE Lambert; Claude F Meares; Agamemnon A Epenetos
Radioimmunotherapy after chemotherapy compared to chemotherapy alone in the treatment of advanced ovarian cancer: a matched analysis.
Oncology reports 1998;5(1):223-6.
1997: DA Goodwin; Claude F Meares
Pretargeting: general principles; October 10-12, 1996.
Cancer 1997;80(12 Suppl):2675-80.
1997: K Murakami; JT Owens; Tamara A Belyaeva; Claude F Meares; Stephen J W Busby; Akira Ishihama
Positioning of two alpha subunit carboxy-terminal domains of RNA polymerase at promoters by two transcription factors.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(21):11274-8.
1997: Sally J DeNardo; Carol M Richman; Desiree S Goldstein; Sui Shen; QA Salako; David L Kukis; Claude F Meares; Aina Yuan; Jeanna Welborn; Gerald L DeNardo
Yttrium-90/indium-111-DOTA-peptide-chimeric L6: pharmacokinetics, dosimetry and initial results in patients with incurable breast cancer.
Anticancer research 1997;17(3B):1735-44.
1997: Sally J DeNardo; David L Kukis; Linda A Kroger; Robert T O'Donnell; Kathleen R Lamborn; Laird A Miers; DG DeNardo; Claude F Meares; Gerald L DeNardo
Synergy of Taxol and radioimmunotherapy with yttrium-90-labeled chimeric L6 antibody: efficacy and toxicity in breast cancer xenografts.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(8):4000-4.
1997: K Murakami; M Kimura; JT Owens; Claude F Meares; Akira Ishihama
The two alpha subunits of Escherichia coli RNA polymerase are asymmetrically arranged and contact different halves of the DNA upstream element.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(5):1709-14.
1997: Marco Chinol; Giovanni Paganelli; F Sudati; Claude F Meares; Ferruccio Fazio
Biodistribution in tumour-bearing mice of two 90Y-labelled biotins using three-step tumour targeting.
Nuclear medicine communications 1997;18(2):176-82.
1997: Gerald L DeNardo; David L Kukis; Sui Shen; LF Mausner; Claude F Meares; Suresh C Srivastava; Laird A Miers; Sally J DeNardo
Efficacy and toxicity of 67Cu-2IT-BAT-Lym-1 radioimmunoconjugate in mice implanted with human Burkitt's lymphoma (Raji).
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(1):71-9.
1997: D P Greiner; R Miyake; J K Moran; A D Jones; T Negishi; Akira Ishihama; Claude F Meares
Synthesis of the protein cutting reagent iron (S)-1-(p-bromoacetamidobenzyl)ethylenediaminetetraacetate and conjugation to cysteine side chains.
Bioconjugate chemistry 1997;8(1):44-8.
1996: L M Rose; A H Gunasekera; Sally J DeNardo; Gerald L DeNardo; Claude F Meares
Lymphoma-selective antibody Lym-1 recognizes a discontinuous epitope on the light chain of HLA-DR10.
Cancer immunology, immunotherapy : CII 1996;43(1):26-30.
1996: D P Greiner; K A Hughes; Claude F Meares
Radiolytic protein surface mapping.
Biochemical and biophysical research communications 1996;225(3):1006-8.
1996: Gerald L DeNardo; Gary R Mirick; Linda A Kroger; Robert T O'Donnell; Claude F Meares; Sally J DeNardo
Antibody responses to macrocycles in lymphoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(3):451-6.
1996: D P Greiner; K A Hughes; A H Gunasekera; Claude F Meares
Binding of the sigma 70 protein to the core subunits of Escherichia coli RNA polymerase, studied by iron-EDTA protein footprinting.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(1):71-5.
1995: M Li; Claude F Meares; QA Salako; David L Kukis; G R Zhong; Laird A Miers; Sally J DeNardo
Prelabeling of chimeric monoclonal antibody L6 with 90yttrium- and 111indium-1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA) chelates for radioimmunodiagnosis and therapy.
Cancer research 1995;55(23 Suppl):5726s-5728s.
1995: G W Philpott; Sally W Schwarz; Carolyn J Anderson; Farrokh Dehdashti; Judith M Connett; K R Zinn; Claude F Meares; PD Cutler; Michael J Welch; Barry A Siegel
RadioimmunoPET: detection of colorectal carcinoma with positron-emitting copper-64-labeled monoclonal antibody.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(10):1818-24.
1995: J B Ghaim; D P Greiner; Claude F Meares; Robert B Gennis
Proximity mapping the surface of a membrane protein using an artificial protease: demonstration that the quinone-binding domain of subunit I is near the N-terminal region of subunit II of cytochrome bd.
Biochemistry 1995;34(36):11311-5.
1995: Carolyn J Anderson; Sally W Schwarz; Judith M Connett; PD Cutler; L W Guo; C J Germain; G W Philpott; K R Zinn; D P Greiner; Claude F Meares
Preparation, biodistribution and dosimetry of copper-64-labeled anti-colorectal carcinoma monoclonal antibody fragments 1A3-F(ab')2.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(5):850-8.
1995: Sally J DeNardo; G R Zhong; QA Salako; M Li; Gerald L DeNardo; Claude F Meares
Pharmacokinetics of chimeric L6 conjugated to indium-111- and yttrium-90-DOTA-peptide in tumor-bearing mice.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(5):829-36.
1995: J K Moran; D P Greiner; Claude F Meares
Improved synthesis of 6-[p-(bromoacetamido)benzyl]-1,4,8,11-tetraazacyclotetradecane- N,N',N",N"-tetraacetic acid and development of a thin-layer assay for thiol-reactive bifunctional chelating agents.
Bioconjugate chemistry 1995;6(3):296-301.
1995: David L Kukis; Gerald L DeNardo; Sally J DeNardo; Gary R Mirick; Laird A Miers; D P Greiner; Claude F Meares
Effect of the extent of chelate substitution on the immunoreactivity and biodistribution of 2IT-BAT-Lym-1 immunoconjugates.
Cancer research 1995;55(4):878-84.
1995: G M Heilek; R Marusak; Claude F Meares; Harry F Noller
Directed hydroxyl radical probing of 16S rRNA using Fe(II) tethered to ribosomal protein S4.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(4):1113-6.
1994: D A Goodwin; Claude F Meares; N Watanabe; M McTigue; W Chaovapong; C M Ransone; Oliver Renn; D P Greiner; David L Kukis; S I Kronenberger
Pharmacokinetics of pretargeted monoclonal antibody 2D12.5 and 88Y-Janus-2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecanetetraacetic acid (DOTA) in BALB/c mice with KHJJ mouse adenocarcinoma: a model for 90Y radioimmunotherapy.
Cancer research 1994;54(22):5937-46.
1994: M Li; Claude F Meares; G R Zhong; Laird A Miers; Cheng-Yi Xiong; Sally J DeNardo
Labeling monoclonal antibodies with 90yttrium- and 111indium-DOTA chelates: a simple and efficient method.
Bioconjugate chemistry 1994;5(2):101-4.
1994: N Watanabe; D A Goodwin; Claude F Meares; M McTigue; W Chaovapong; C M Ransone; Oliver Renn
Immunogenicity in rabbits and mice of an antibody-chelate conjugate: comparison of (S) and (R) macrocyclic enantiomers and an acyclic chelating agent.
Cancer research 1994;54(4):1049-54.
1994: David L Kukis; H Diril; D P Greiner; Sally J DeNardo; Gerald L DeNardo; QA Salako; Claude F Meares
A comparative study of copper-67 radiolabeling and kinetic stabilities of antibody-macrocycle chelate conjugates.
Cancer 1994;73(3 Suppl):779-86.
1994: A Maraveyas; D Snook; V Hird; Christos Kosmas; Claude F Meares; HE Lambert; Agamemnon A Epenetos
Pharmacokinetics and toxicity of an yttrium-90-CITC-DTPA-HMFG1 radioimmunoconjugate for intraperitoneal radioimmunotherapy of ovarian cancer.
Cancer 1994;73(3 Suppl):1067-75.
1994: Gerald L DeNardo; Linda A Kroger; Sally J DeNardo; Laird A Miers; QA Salako; David L Kukis; I Fand; Sui Shen; Oliver Renn; Claude F Meares
Comparative toxicity studies of yttrium-90 MX-DTPA and 2-IT-BAD conjugated monoclonal antibody (BrE-3).
Cancer 1994;73(3 Suppl):1012-22.
1993: V Hird; A Maraveyas; D Snook; B Dhokia; W P Soutter; Claude F Meares; J S Stewart; P Mason; HE Lambert; Agamemnon A Epenetos
Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody.
British journal of cancer 1993;68(2):403-6.
1993: Xu-Bao Shi; Paul H Gumerlock; A A Wellman; Claude F Meares; Gerald L DeNardo; Frederick J Meyers; Sally J DeNardo
Rapid PCR construction of a gene containing Lym-1 antibody variable regions.
PCR methods and applications 1993;3(1):46-53.
1993: M Li; Claude F Meares
Synthesis, metal chelate stability studies, and enzyme digestion of a peptide-linked DOTA derivative and its corresponding radiolabeled immunoconjugates.
Bioconjugate chemistry 1993;4(4):275-83.
1992: Oliver Renn; Claude F Meares
Large-scale synthesis of the bifunctional chelating agent 2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetr aacetic acid, and the determination of its enantiomeric purity by chiral chromatography.
Bioconjugate chemistry 1992;3(6):563-9.
1992: D A Goodwin; Claude F Meares; M McTigue; W Chaovapong; C I Diamanti; C H Ransone; M J McCall
Pretargeted immunoscintigraphy: effect of hapten valency on murine tumor uptake.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(11):2006-13.
1992: Carolyn J Anderson; Judith M Connett; Sally W Schwarz; P A Rocque; L W Guo; G W Philpott; K R Zinn; Claude F Meares; Michael J Welch
Copper-64-labeled antibodies for PET imaging.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(9):1685-91.
1992: M Studer; Linda A Kroger; Sally J DeNardo; David L Kukis; Claude F Meares
Influence of a peptide linker on biodistribution and metabolism of antibody-conjugated benzyl-EDTA. Comparison of enzymatic digestion in vitro and in vivo.
Bioconjugate chemistry 1992;3(5):424-9.
1992: M Studer; Claude F Meares
A convenient and flexible approach for introducing linkers on bifunctional chelating agents.
Bioconjugate chemistry 1992;3(5):420-3.
1992: M Studer; Claude F Meares
Synthesis of novel 1,4,7-triazacyclononane-N,N',N"-triacetic acid derivatives suitable for protein labeling.
Bioconjugate chemistry 1992;3(4):337-41.
1992: Christos Kosmas; D Snook; C S Gooden; N S Courtenay-Luck; M J McCall; Claude F Meares; Agamemnon A Epenetos
Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy.
Cancer research 1992;52(4):904-11.
1991: T M Rana; Claude F Meares
Transfer of oxygen from an artificial protease to peptide carbon during proteolysis.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(23):10578-82.
1991: V Hird; M Verhoeyen; R A Badley; D Price; D Snook; Christos Kosmas; C Gooden; A Bamias; Claude F Meares; J P Lavender
Tumour localisation with a radioactively labelled reshaped human monoclonal antibody.
British journal of cancer 1991;64(5):911-4.
1991: A Wellman; Claude F Meares
Footprint of the sigma protein: a re-examination.
Biochemical and biophysical research communications 1991;177(1):140-4.
1991: C J Mathias; M J Welch; M A Green; H Diril; Claude F Meares; R J Gropler; Steven Bergmann
In vivo comparison of copper blood-pool agents: potential radiopharmaceuticals for use with copper-62.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1991;32(3):475-80.
1991: Gerald L DeNardo; Sally J DeNardo; David L Kukis; H Diril; C Suey; Claude F Meares
Strategies for enhancement of radioimmunotherapy.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1991;18(6):633-40.
1990: S H Northrup; T G Wensel; Claude F Meares; J J Wendoloski; J B Matthew
Electrostatic field around cytochrome c: theory and energy transfer experiment.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(23):9503-7.
1990: A A Wellman; Claude F Meares
Sequences of the Lym-1 antibody heavy and light chain variable regions.
Nucleic acids research 1990;18(17):5281.
1990: T M Rana; Claude F Meares
N-terminal modification of immunoglobulin polypeptide chains tagged with isothiocyanato chelates.
Bioconjugate chemistry 1990;1(5):357-62.
1990: Claude F Meares; M K Moi; H Diril; David L Kukis; M J McCall; S V Deshpande; Sally J DeNardo; D Snook; Agamemnon A Epenetos
Macrocyclic chelates of radiometals for diagnosis and therapy.
The British journal of cancer. Supplement 1990;10():21-6.
1990: M J McCall; H Diril; Claude F Meares
Simplified method for conjugating macrocyclic bifunctional chelating agents to antibodies via 2-iminothiolane.
Bioconjugate chemistry 1990;1(3):222-6.
1990: S V Deshpande; Sally J DeNardo; David L Kukis; M K Moi; M J McCall; Gerald L DeNardo; Claude F Meares
Yttrium-90-labeled monoclonal antibody for therapy: labeling by a new macrocyclic bifunctional chelating agent.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(4):473-9.
1990: B Bartholomew; Claude F Meares; Michael E Dahmus
Photoaffinity labeling of RNA polymerase III transcription complexes by nascent RNA.
The Journal of biological chemistry 1990;265(7):3731-7.
1990: M K Moi; Sally J DeNardo; Claude F Meares
Stable bifunctional chelates of metals used in radiotherapy.
Cancer research 1990;50(3 Suppl):789s-793s.
1990: S V Deshpande; R Subramanian; M J McCall; Sally J DeNardo; Gerald L DeNardo; Claude F Meares
Metabolism of indium chelates attached to monoclonal antibody: minimal transchelation of indium from benzyl-EDTA chelate in vivo.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(2):218-24.
1990: Sally J DeNardo; S V Deshpande; M K Moi; G P Adamas; M K McCall; Gerald L DeNardo; Claude F Meares
Today and tomorrow: radiochemistry for radioimmunotherapy of breast cancer.
Frontiers of radiation therapy and oncology 1990;24():142-50; discussion 161-5.
1990: R Subramanian; Claude F Meares
Bifunctional chelating agents for radiometal-labeled monoclonal antibodies.
Cancer treatment and research 1990;51():183-99.
1989: T M Stackhouse; Alice Telesnitsky; Claude F Meares
Release of the sigma subunit from Escherichia coli RNA polymerase transcription complexes is dependent on the promoter sequence.
Biochemistry 1989;28(19):7781-8.
1989: U Ramesh; Claude F Meares
Footprint of the sigma protein.
Biochemical and biophysical research communications 1989;160(1):121-5.
1989: G P Adams; Sally J DeNardo; S V Deshpande; Gerald L DeNardo; Claude F Meares; M J McCall; A L Epstein
Effect of mass of 111In-benzyl-EDTA monoclonal antibody on hepatic uptake and processing in mice.
Cancer research 1989;49(7):1707-11.
1989: S V Deshpande; Sally J DeNardo; Claude F Meares; M J McCall; G P Adams; Gerald L DeNardo
Effect of different linkages between chelates and monoclonal antibodies on levels of radioactivity in the liver.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1989;16(6):587-97.
1988: M K Moi; Claude F Meares; S J Denardo
The peptide way to macrocyclic bifunctional chelating agents: synthesis of 2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecane-N,N',N",N'''-tetraacetic acid and study of its yttrium(III) complex.
Journal of the American Chemical Society 1988;110(18):6266-7.
1988: T M Stackhouse; Claude F Meares
Photoaffinity labeling of Escherichia coli RNA polymerase/poly[d(A-T)] transcription complexes by nascent RNA.
Biochemistry 1988;27(8):3038-45.
1988: D A Goodwin; Claude F Meares; M J McCall; M McTigue; W Chaovapong
Pre-targeted immunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1988;29(2):226-34.
1988: S V Deshpande; Sally J DeNardo; Claude F Meares; M J McCall; G P Adams; M K Moi; Gerald L DeNardo
Copper-67-labeled monoclonal antibody Lym-1, a potential radiopharmaceutical for cancer therapy: labeling and biodistribution in RAJI tumored mice.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1988;29(2):217-25.
1988: Claude F Meares; M J McCall; S V Deshpande; Sally J DeNardo; D A Goodwin
Chelate radiochemistry: cleavable linkers lead to altered levels of radioactivity in the liver.
International journal of cancer. Supplement = Journal international du cancer. Supplement 1988;2():99-102.
1987: W C Cole; Sally J DeNardo; Claude F Meares; M J McCall; Gerald L DeNardo; A L Epstein; H A O'Brien; M K Moi
Comparative serum stability of radiochelates for antibody radiopharmaceuticals.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1987;28(1):83-90.
1987: M H Penner; D T Osuga; Claude F Meares; R E Feeney
The interaction of anions with native and phenylglyoxal-modified human serum transferrin.
Archives of biochemistry and biophysics 1987;252(1):7-14.
1986: D A Goodwin; Claude F Meares; M McTigue; M J McCall; W Chaovapong
Metal decomposition rates of 111In-DTPA and EDTA conjugates of monoclonal antibodies in vivo.
Nuclear medicine communications 1986;7(11):831-8.
1986: B Bartholomew; Michael E Dahmus; Claude F Meares
RNA contacts subunits IIo and IIc in HeLa RNA polymerase II transcription complexes.
The Journal of biological chemistry 1986;261(30):14226-31.
1986: S L Bernhard; Claude F Meares
Accessibility of the leading end of ribonucleic acid in transcription complexes.
Biochemistry 1986;25(21):6397-404.
1986: S L Bernhard; Claude F Meares
The sigma subunit of RNA polymerase contacts the leading ends of transcripts 9-13 bases long on the lambda PR promoter but not on T7 A1.
Biochemistry 1986;25(20):5914-9.
1986: T G Wensel; Claude F Meares; V Vlachy; J B Matthew
Distribution of ions around DNA, probed by energy transfer.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(10):3267-71.
1986: W C Cole; Sally J DeNardo; Claude F Meares; M J McCall; Gerald L DeNardo; A L Epstein; H A O'Brien; M K Moi
Serum stability of 67Cu chelates: comparison with 111In and 57Co.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1986;13(4):363-8.
1986: M K Haseman; D A Goodwin; Claude F Meares; Mark S Kaminski; T G Wensel; M J McCall; Ronald Levy
Metabolizable 111In chelate conjugated anti-idiotype monoclonal antibody for radioimmunodetection of lymphoma in mice.
European journal of nuclear medicine 1986;12(9):455-60.
1986: D A Goodwin; Claude F Meares; G F David; M McTigue; M J McCall; J M Frincke; M R Stone; Richard Bartholomew; J P Leung
Monoclonal antibodies as reversible equilibrium carriers of radiopharmaceuticals.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1986;13(4):383-91.
1986: Claude F Meares
Chelating agents for the binding of metal ions to antibodies.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1986;13(4):311-8.
1985: R Subramanian; Claude F Meares
Photo-induced nicking of deoxyribonucleic acid by ruthenium(II)-bleomycin in the presence of air.
Biochemical and biophysical research communications 1985;133(3):1145-51.
1985: D T Reardan; Claude F Meares; D A Goodwin; M McTigue; G S David; M R Stone; J P Leung; Richard Bartholomew; J M Frincke
Antibodies against metal chelates.
Nature 1985;316(6025):265-8.
1985: M K Moi; Claude F Meares; M J McCall; W C Cole; Sally J DeNardo
Copper chelates as probes of biological systems: stable copper complexes with a macrocyclic bifunctional chelating agent.
Analytical biochemistry 1985;148(1):249-53.
1985: T G Wensel; C H Chang; Claude F Meares
Diffusion-enhanced lanthanide energy-transfer study of DNA-bound cobalt(III) bleomycins: comparisons of accessibility and electrostatic potential with DNA complexes of ethidium and acridine orange.
Biochemistry 1985;24(12):3060-9.
1985: D A Goodwin; Claude F Meares; M J McCall; M K Haseman; M McTigue; C I Diamanti; W Chaovapong
Chelate conjugates of monoclonal antibodies for imaging lymphoid structures in the mouse.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1985;26(5):493-502.
1985: M H Penner; D T Osuga; Claude F Meares; R E Feeney
Interaction of oxidized chicken ovotransferrin with chicken embryo red blood cells.
Biochimica et biophysica acta 1985;827(3):389-95.
1984: Claude F Meares; M J McCall; D T Reardan; D A Goodwin; C I Diamanti; M McTigue
Conjugation of antibodies with bifunctional chelating agents: isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions.
Analytical biochemistry 1984;142(1):68-78.
1984: A Abusaleh; Claude F Meares
Excitation and de-excitation processes in lanthanide chelates bearing aromatic sidechains.
Photochemistry and photobiology 1984;39(6):763-9.
1984: C H Chang; Claude F Meares
Cobalt-bleomycins and deoxyribonucleic acid: sequence-dependent interactions, action spectrum for nicking, and indifference to oxygen.
Biochemistry 1984;23(10):2268-74.
1984: D J Sartoris; D A Goodwin; Claude F Meares; L H DeRiemer; L F Fajardo
Pharmacokinetics of indium-111 BLEDTA in man.
Investigative radiology 1984;19(3):221-7.
1984: D Goodwin; Claude F Meares; C Diamanti; M McCall; C Lai; F Torti; M McTigue; B Martin
Use of specific antibody for rapid clearance of circulating blood background from radiolabeled tumor imaging proteins.
European journal of nuclear medicine 1984;9(5):209-15.
1983: M H Penner; R B Yamasaki; D T Osuga; D R Babin; Claude F Meares; R E Feeney
Comparative oxidations of tyrosines and methionines in transferrins: human serum transferrin, human lactotransferrin, and chicken ovotransferrin.
Archives of biochemistry and biophysics 1983;225(2):740-7.
1983: M M Hanna; Claude F Meares
Synthesis of a cleavable dinucleotide photoaffinity probe of ribonucleic acid polymerase: application to trinucleotide labeling of an Escherichia coli transcription complex.
Biochemistry 1983;22(15):3546-51.
1983: M M Hanna; Claude F Meares
Topography of transcription: path of the leading end of nascent RNA through the Escherichia coli transcription complex.
Proceedings of the National Academy of Sciences of the United States of America 1983;80(14):4238-42.
1983: C H Chang; J L Dallas; Claude F Meares
Identification of a key structural feature of cobalt(III)-bleomycins: an exogenous ligand (e.g. hydroperoxide) bound to cobalt.
Biochemical and biophysical research communications 1983;110(3):959-66.
1982: C H Chang; Claude F Meares
Light-induced nicking of deoxyribonucleic acid by cobalt(III) bleomycins.
Biochemistry 1982;21(25):6332-4.
1982: L S Rice; Claude F Meares
Effects of sigma subunit and DNA template on the accessibility of rifamycin bound to RNA polymerase.
Biochemical and biophysical research communications 1982;105(1):51-6.
1982: L Stryer; D D Thomas; Claude F Meares
Diffusion-enhanced fluorescence energy transfer.
Annual review of biophysics and bioengineering 1982;11():203-22.
1981: D A Goodwin; Claude F Meares; L H DeRiemer; C I Diamanti; R L Goode; J E Baumert; D J Sartoris; R L Lantieri; H D Fawcett
Clinical studies with In-111 BLEDTA, a tumor-imaging conjugate of bleomycin with a bifunctional chelating agent.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1981;22(9):787-92.
1981: P O'Hara; S M Yeh; Claude F Meares; R Bersohn
Distance between metal-binding sites in transferrin: energy transfer from bound terbium (III) to iron (III) or manganese (III).
Biochemistry 1981;20(16):4704-8.
1981: L H DeRiemer; Claude F Meares
Early steps in the path of nascent ribonucleic acid across the surface of ribonucleic acid polymerase, determined by photoaffinity labeling.
Biochemistry 1981;20(6):1612-7.
1981: L H DeRiemer; Claude F Meares
Synthesis of mono- and dinucleotide photoaffinity probes of ribonucleic acid polymerase.
Biochemistry 1981;20(6):1606-12.
1981: Claude F Meares; L S Rice
Diffusion-enhanced energy transfer shows accessibility of ribonucleic acid polymerase inhibitor binding sites.
Biochemistry 1981;20(3):610-7.
1981: R J Baker; C I Diamanti; D A Goodwin; Claude F Meares
Technetium-99 m complexes of EDTA analogs: studies of the radiochemistry and biodistribution.
International journal of nuclear medicine and biology 1981;8(2-3):159-69.
1980: S M Yeh; Claude F Meares
Characterization of transferrin metal-binding sites by diffusion-enhanced energy transfer.
Biochemistry 1980;19(22):5057-62.
1980: Claude F Meares; S M Yeh; L S Rice
Diffusion-enhanced lanthanide energy transfer studies of protein prosthetic groups.
Biophysical journal 1980;32(1):228-30.
1980: M J Lipton; P W Doherty; D A Goodwin; G T Bushberg; R Prager; Claude F Meares
Evaluation of catheter thrombogenicity in vivo with indium-labeled platelets.
Radiology 1980;135(1):191-4.
1979: S M Yeh; D G Sherman; Claude F Meares
A new route to "bifunctional" chelating agents: conversion of amino acids to analogs of ethylenedinitrilotetraacetic acid.
Analytical biochemistry 1979;100(1):152-9.
1979: L H DeRiemer; Claude F Meares; D A Goodwin; C I Diamanti
BLEDTA: tumor localization by a bleomycin analogue containing a metal-chelating group.
Journal of medicinal chemistry 1979;22(9):1019-23.
1979: S M Yeh; Claude F Meares
Amphiphilic spectroscopic probes utilizing metal chelates.
Experientia 1979;35(6):715-6.
1978: C S Leung; Claude F Meares; D A Goodwin
The attachment of metal-chelating groups to protein: tagging of albumin by diazonium coupling and use of the products as radiopharmaceuticals.
The International journal of applied radiation and isotopes 1978;29(11):687-92.
1978: D A Goodwin; J T Bushberg; P W Doherty; M J Lipton; F K Conley; C I Diamanti; Claude F Meares
Indium-111-labeled autologous platelets for location of vascular thrombi in humans.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1978;19(6):626-34.
1978: P W Doherty; J T Bushberg; M J Lipton; Claude F Meares; D A Goodwin
The use of indium-111-labeled leukocytes for abscess detection.
Clinical nuclear medicine 1978;3(3):108-10.
1978: L S Rice; Claude F Meares
Subunit contacts of the rifamycin binding site of RNA polymerase (B. subtilis).
Biochemical and biophysical research communications 1978;80(1):26-32.
1977: Claude F Meares; J E Ledbetter
Energy transfer between terbium and iron bound to transferrin: reinvestigation of the distance between metal-binding sites.
Biochemistry 1977;16(24):5178-80.
1977: Terry B Rogers; R E Feeney; Claude F Meares
Interaction of anions with iron-transferrin-chelate complexes.
The Journal of biological chemistry 1977;252(22):8108-12.
1977: S M Halling; F J Sanchez-Anzaldo; R Fukuda; R H Doi; Claude F Meares
Zinc is associated with the beta subunit of DNA-dependent RNA polymerase of Bacillus subtilis.
Biochemistry 1977;16(13):2880-4.
1977: C S Leung; Claude F Meares
Attachment of fluorescent metal chelates to macromolecules using "bifunctional" chelating agents.
Biochemical and biophysical research communications 1977;75(1):149-55.
1976: Claude F Meares; D A Goodwin; C S Leung; A Y Girgis; D J Silvester; Adrian Nunn; P J Lavender
Covalent attachment of metal chelates to proteins:the stability in vivo and in vitro of the conjugate of albumin with a chelate of 111indium.
Proceedings of the National Academy of Sciences of the United States of America 1976;73(11):3803-6.
1976: D A Goodwin; Claude F Meares
Radiolabeled antitumor agents.
Seminars in nuclear medicine 1976;6(4):389-96.
1975: D A Goodwin; Claude F Meares; C I Diamanti; M W Sundberg
Bifunctional chelates for radio-pharmaceutical labeling.
Nuclear-Medizin 1975;14(4):365-73.
1974: M W Sundberg; Claude F Meares; D A Goodwin; C I Diamanti
Selective binding of metal ions to macromolecules using bifunctional analogs of EDTA.
Journal of medicinal chemistry 1974;17(12):1304-7.
1974: M W Sundberg; Claude F Meares; D A Goodwin; C I Diamanti
Chelating agents for the binding of metal ions to macromolecules.
Nature 1974;250(467):587-8.
1972: Claude F Meares; M W Sundberg; J D Baldeschwieler
Perturbed angular correlation study of a haptenic molecule.
Proceedings of the National Academy of Sciences of the United States of America 1972;69(12):3718-22.
1972: D A Goodwin; Claude F Meares; C H Song
The study of 111 In-labeled compounds in mice, using perturbed angular correlations of gamma radiations.
Radiology 1972;105(3):699-702.
1972: Claude F Meares; D G Westmoreland
The study of biological macromolecules using perturbed angular correlations of gamma radiation.
Cold Spring Harbor symposia on quantitative biology 1972;36():511-6.
1969: Claude F Meares; R G Bryant; J D Baldeschwieler; D A Shirley
Study of carbonic anhydrase using perturbed angular correlations of gamma radiation.
Proceedings of the National Academy of Sciences of the United States of America 1969;64(4):1155-61.